These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21220399)
1. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399 [TBL] [Abstract][Full Text] [Related]
2. Advances in management of low-risk febrile neutropenia. Teuffel O; Sung L Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219 [TBL] [Abstract][Full Text] [Related]
3. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075 [TBL] [Abstract][Full Text] [Related]
4. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527 [TBL] [Abstract][Full Text] [Related]
5. Is it time to redefine the management of febrile neutropenia in cancer patients? Anaissie EJ; Vadhan-Raj S Am J Med; 1995 Mar; 98(3):221-3. PubMed ID: 7872336 [No Abstract] [Full Text] [Related]
6. Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy. Cosler LE; Sivasubramaniam V; Agboola O; Crawford J; Dale D; Lyman GH Value Health; 2005; 8(1):47-52. PubMed ID: 15841893 [TBL] [Abstract][Full Text] [Related]
7. Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis. Avilés-Robles MJ; Reyes-López A BMC Health Serv Res; 2024 Aug; 24(1):981. PubMed ID: 39182090 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices. Elting LS; Cantor SB Support Care Cancer; 2002 Apr; 10(3):189-96. PubMed ID: 11904783 [TBL] [Abstract][Full Text] [Related]
9. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children. Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML Value Health; 2003; 6(2):158-66. PubMed ID: 12641866 [TBL] [Abstract][Full Text] [Related]
10. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey. Boragina M; Patel H; Reiter S; Dougherty G Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314 [TBL] [Abstract][Full Text] [Related]
11. Evolving concepts of management of febrile neutropenia in children with cancer. Orudjev E; Lange BJ Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054 [TBL] [Abstract][Full Text] [Related]
12. A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment. Lingaratnam S; Worth LJ; Slavin MA; Bennett CA; Kirsa SW; Seymour JF; Dalton A; Koczwara B; Prince HM; O'Reilly M; Mileshkin L; Szer J; Thursky KA Aust Health Rev; 2011 Nov; 35(4):491-500. PubMed ID: 22126955 [TBL] [Abstract][Full Text] [Related]
13. Are we finally ready for outpatient management of febrile neutropenia? Saini S; Rosoff PM Pediatr Blood Cancer; 2007 Nov; 49(6):765-6. PubMed ID: 17514730 [No Abstract] [Full Text] [Related]
14. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV J Pediatr Hematol Oncol; 1999; 21(3):212-8. PubMed ID: 10363854 [TBL] [Abstract][Full Text] [Related]
15. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Courtney DM; Aldeen AZ; Gorman SM; Handler JA; Trifilio SM; Parada JP; Yarnold PR; Bennett CL Oncologist; 2007 Aug; 12(8):1019-26. PubMed ID: 17766662 [TBL] [Abstract][Full Text] [Related]
16. Outpatient therapy for febrile neutropenia: clinical and economic implications. de Lalla F Pharmacoeconomics; 2003; 21(6):397-413. PubMed ID: 12678567 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. Teuffel O; Amir E; Alibhai S; Beyene J; Sung L Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048 [TBL] [Abstract][Full Text] [Related]
18. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer. Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377 [TBL] [Abstract][Full Text] [Related]
19. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J; Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital. Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]